Richard William Scalzo - 18 Sep 2023 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Senior Vice President, Head of Finance and Administration
Signature
/s/ Richard Scalzo
Issuer symbol
DYN
Transactions as of
18 Sep 2023
Net transactions value
-$12,139
Form type
4
Filing time
20 Sep 2023, 16:49:38 UTC
Previous filing
13 Sep 2023
Next filing
16 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DYN Common Stock Sale $12,139 -1,290 -3.1% $9.41 40,795 18 Sep 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on September 17, 2020. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.
F2 Includes 37,451 unvested RSUs.

Remarks:

Senior Vice President, Head of Finance and Administration